Bioprinting News and Research

RSS

Bioprinting involves the use of 3D printing technology to build tissues and organs. Bioprinting precisely places cells, proteins, DNA, drug particles, growth factors and biologically active particles spatially to guide tissue generation and formation. It has been used extensively in the field of regenerative medicine.

Electro-bioprinting as a Tool to Study Early Human Embryonic Development

Bioprinted epiblast-like structures mimic early human embryonic development, offering a scalable, ethical platform to study gastrulation and tissue formation.

11 Jun 2025

3D Printing Collagen Scaffolds with Perfusable Systems for Tissue Engineering

Scientists have developed high-resolution 3D-printed collagen scaffolds with internal perfusion systems, enabling complex, vascularized tissue models that support cell viability, growth, and insulin secretion

6 May 2025

New Approach Aims to Make CRISPR Therapy Safer and More Effective

CRISPR is a powerful gene-editing tool that holds enormous potential for treating genetic diseases by allowing scientists to cut, replace, or delete mutations in DNA.

16 Jan 2025

Mucus-Based Bioink Shows Promise for 3D-Printed Lung Tissue

Each year, lung illnesses claim the lives of millions of people worldwide. There are few available treatments, and animal models used to research these conditions and potential drugs are insufficient. Researchers have now successfully developed a mucus-based bioink for 3D printing lung tissue.

31 Jul 2024

Transition to Laser-Based 3D Bioprinting: Stride Towards Addressing Organ Shortage

Recent advancements in laser technology are leading to groundbreaking developments in the medical field, from improved treatment of cardiovascular diseases to higher-precision manufacturing of medical devices.

7 Mar 2024

Could Bio-Printing Be the Future of Affordable and Personalized Healthcare?

Healthcare costs are increasing at record rates around the world, at a global average of 10% from 2022 to 2023, according to the 2023 Global Medical Trends Survey.

16 Jan 2024

Combating the Illegal Organ Trade with Bio-Printing

The World Health Organization (WHO) estimates that there are not enough legally available organs for transplantation to meet even 10% of worldwide demand.

19 Dec 2023

FluidForm Bio 3D Bioprints Human Cardiac Tissue for Drug Development Breakthrough

FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH 3D bioprinting.

13 Dec 2023

A Glimpse into Future: Bioprinted Organs May Become Reality in Two Decades

In recent years, 3D printing has emerged as a transformative technology for the field of organ transplantation. Doctors are already using 3D-printed skin for burn treatment and wound healing, and this year has seen the first successful use of 3D-printed cartilage for ear reconstruction.

22 Nov 2023

Biofabrication of Engineering Living Systems With Single-Cell Resolution

The recent advances in biofabrication with extremely high resolution (e.g. at the single-cell level) have greatly enhanced the capacity of biofabrication and opened new avenues for tissue engineering.

2 Nov 2023

Unlocking the Potential of Lab-Made Hydrogel for Tissue Growth and Medical Applications

A recently developed laboratory-created material imitates human tissue and has the potential to decrease or substitute for the utilization of animal-derived components in biomedical studies.

24 Oct 2023

A Biocompatible Method for Making Complex Cell-Based Soft 3D Architectures

What if it was possible to heal organ damage simply by generating a new organ in the lab?

16 Oct 2023

Bioprinted Neural Networks Mimic Brain Circuitsdani

Researchers from Monash University’s Engineering Department have achieved a significant breakthrough by using “bioinks” that include living nerve cells (neurons) to 3D print nerve networks.

22 Sep 2023

Next Step in Sartorius Partnership Finalized: Several Subsales and Distribution Agreements as Well as R&D Project Agreements Have Been Signed

During May and June 2023 several sub-sales and distribution agreements were signed between Sartorius and BICO companies CELLINK, Advanced BioMatrix (ABM) and Dispendix.

From BICO 5 Jul 2023

Achieving 3D Printing Inside 'Mini-Organs' Growing in Hydrogels

Scientists from the NIHR Great Ormond Street Hospital Biomedical Research Centre (a collaboration between GOSH and UCL), London, and University of Padova, Italy, have shown for the first time how 3D printing can be achieved inside 'mini-organs' growing in hydrogels -- controlling their shape, activity, and even forcing tissue to grow into 'molds.'

12 Jun 2023

Novel Technique Overcomes Challenges of Bioprinting

Printing living cells into functional tissues is a highly complex process, and with each technological advancement, new challenges emerge. The Levato lab at UMC Utrecht has successfully combined two promising printing processes to boost cell density, cell survival, and specialization in bioprints. The solution: granular biogels or resins.

8 Jun 2023

Researchers Publish a Detailed Protocol for Making Three Cell Types From iPSCs

Researchers at NIH's National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries.

17 May 2023

Novel 3D Bioink Induces Organ Regeneration

The advancement of biomaterials for artificial organs and tissues is active due to the rise in accidental injuries and chronic diseases, together with the entry into a super-aged society.

17 Apr 2023

Innovative method to quickly identify bacteria in fluids

Shine a laser on a drop of blood, mucus, or wastewater, and the light reflecting back can be used to positively identify bacteria in the sample.

3 Mar 2023

Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery

Inventia Life Science, a world leader in advanced cell models for biomedical research and drug discovery, today announced a collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) using Inventia’s RASTRUM™ 3D cell culture platform.

From Inventia Life Science 16 Feb 2023